,20 However, owing to the small number of patients in DESTINY-Gastric06 who had a new tumor sample collected to determine HER2 status during the study screening period, further investigation is needed into the potential effect of prior HER2-directed therapies and HER2 expression. This evidence concerns the gene ERBB2 and neoplasm.